Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54,284,692
-
Total 13F shares
-
42,074,592
-
Share change
-
+39,613,174
-
Total reported value
-
$690,108,943
-
Price per share
-
$16.44
-
Number of holders
-
70
-
Value change
-
+$649,643,232
-
Number of buys
-
66
Institutional Holders of Upstream Bio, Inc. - Common Stock, par value $0.001 per share (UPB) as of Q4 2024
As of 31 Dec 2024 Upstream Bio, Inc. - Common Stock, par value $0.001 per share (UPB) had 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 42,074,592 shares of stock of the company.
Largest 10 holders included FMR LLC, ORBIMED ADVISORS LLC, Decheng Capital LLC, TCG Crossover Management, LLC, Enavate Sciences GP, LLC, Bain Capital Life Sciences Investors, LLC, VR Adviser, LLC, Samsara BioCapital, LLC, Omega Fund Management, LLC, and WELLINGTON MANAGEMENT GROUP LLP.
This table shows 70 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.